Status:
TERMINATED
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Lead Sponsor:
Stanford University
Conditions:
Lung Cancer
Lung Cancer Non-Small Cell Cancer (NSCLC)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The stereotactic body radiation therapy (SBRT) procedure is an emerging alternative to the standard treatment for early stage non-small cell lung cancer (NSCLC), typically lobectomy with lymphadenecto...
Detailed Description
Non-small cell lung cancer (NSCLC) is the most deadly cancer in the world. NSCLC annually causes 150,000 deaths in the US and greater than 1 million worldwide. The standard treatment for early stage N...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- Either:
- Established primary lung cancer/ cancer metastatic to lung, OR
- Lesion suspicious for malignancy in lung, according to the following criteria:
- Histopathologically confirmed lung cancer or cancer metastatic to lung, OR
- Plan for biopsy of suspicious lung mass based on imaging (growth on serial CT scan or nodule/mass with focal hypermetabolism on FDG-PET scan), OR
- Known metastatic cancer, with metastases to the lung based on imaging
- Age \> 18 years old
- Eastern Clinical Oncology Group (ECOG) performance status 0, 1 or 2 (Appendix IV)
- No prior surgery, chemotherapy, or radiation for the current lung tumor
- EXCLUSION CRITERIA
- Prior radiotherapy to thorax
- Iodine allergy
- Contraindication to receiving radiotherapy, unless undergoing surgery
- Pregnant
Exclusion
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01188486
Start Date
August 1 2010
End Date
April 30 2017
Last Update
April 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305